Subscribe to RSS

DOI: 10.1055/s-0041-1740533
Guia de cáncer de pene de la Sociedad Colombiana de Urología
Colombian Society of Urology Penile Cancer Guideline
Resumen
El cáncer de pene tiene una incidencia de 1.11 por 100.000 habitantes en Colombia, representado en el 95% por carcinoma de células escamosas el cual representa una alta morbilidad y mortalidad, La Sociedad Colombiana de Urología realizo la adaptación de la guía de cáncer de pene para el año 2021 con revisión de la literatura, esta guía permite realizar una evaluación y tratamiento del cáncer de pene, en muchas ocasiones con el objetivo de preservación de órgano utilizando la ecografía como determinante para evaluar el compromiso de la lesión a las estructuras del pene, los estudios de extensión dependerán de hallazgos al examen físico como ganglios o compromiso local de la enfermedad, de acuerdo al tipo de lesión y su estadificación puede recibir terapia con agentes tópicos, radioterapia, cirugía láser, cirugía preservadora de órgano o penectomía total; La linfadenectomía inguinal permitirá mejorar la supervivencia en tumores de riesgo intermedio y alto (>pT1G2), posteriormente la quimioterapia adyuvante esta en el grupo de pacientes en el cual la intención sea curativa, aunque en terapia paliativa de segunda línea se encuentran los platinos y texanos como alternativa pero con pobre respuesta (<30%); los esquemas de seguimiento se realiza de acuerdo al estadio y el compromiso ganglionar. Al final se presentan los resultados de actividad sexual después de cirugía preservadora de órgano; Esta guía abarca la literatura actualizada del cáncer de pene, el cual es útil para el manejo por parte de los profesionales de salud del país.
Abstract
Penile cancer has an incidence of 1.11 per 100,000 inhabitants in Colombia, 95% represented by squamous cell carcinoma which represents a high morbidity and mortality, The Colombian Society of Urology adapted the penile cancer guide to The year 2021 with a review of the literature, this guide allows an evaluation and treatment of penile cancer, in many cases with the objective of organ preservation, using ultrasound as a determinant to evaluate the commitment of the injury to the structures of the penis, Extension studies will depend on findings on physical examination such as lymph nodes or local involvement of the disease, according to the type of lesion and its staging, it can receive therapy with topical agents, radiotherapy, laser surgery, organ-sparing surgery or total penectomy; Inguinal lymphadenectomy will improve survival in intermediate and high risk tumors (> pT1G2), subsequently adjuvant chemotherapy is in the group of patients in which the intention is curative, although platinum and Texans are found in second-line palliative therapy as an alternative but with a poor response (<30%); the follow-up schemes are carried out according to the stage and lymph node involvement. At the end, the results of sexual activity after organ-sparing surgery are presented; This guide covers the updated literature on penile cancer, which is useful for the management of health professionals in the country.
Palabras clave
neoplasias de pene - pene - recurrencia de neoplasia local preservación de órgano - carcinoma - escamo celular - mortalidadKeywords
penile neoplasms - penis - local neoplasm recurrence - organ sparing treatments - carcinoma - squamous cell - mortalityPublication History
Received: 08 December 2021
Accepted: 08 October 2021
Article published online:
31 March 2022
© 2022. Sociedad Colombiana de Urología. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
Referencias
- 1 World health organization. International agency for research on cancer, Cancer Today - IARC, 150 Cours Albert Thomas, 69372 Lyon CEDEX 08, France; powered by GLOBOCAN. 2020 https://gco.iarc.fr/today/online-analysis
- 2 Cataño JGC, Pérez Niño JF, Schlesinger AA.. Manejo actual del cáncer de pene en el Hospital Universitario de San Ignacio. Urología Colombiana 2010; 19 (01) 13-184
- 3 Ramírez G, Bermúdez AJ. Carcinoma de Pene Hospital Universitario del Valle, Urolo.colom. 2004 , 13
- 4 Velazquez EF, Barreto JE, Rodriguez I, Piris A, Cubilla AL. Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol 2004; 12 (02) 139-146 https://www.ncbi.nlm.nih.gov/pubmed/15173919
- 5 Velazquez EF, Cubilla AL. Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am J Surg Pathol 2003; 27 (11) 1448-1453 https://www.ncbi.nlm.nih.gov/pubmed/14576478
- 6 Teichman JM, Sea J, Thompson IM, Elston DM. Noninfectious penile lesions. Am Fam Physician 2010; 81 (02) 167-174 https://www.ncbi.nlm.nih.gov/pubmed/20082512
- 7 Renaud-Vilmer C, Cavelier-Balloy B, Verola O. et al. Analysis of alterations adjacent to invasive squamous cell carcinoma of the penis and their relationship with associated carcinoma. J Am Acad Dermatol 2010; 62 (02) 284-290 https://www.ncbi.nlm.nih.gov/pubmed/20115951
- 8 Muñoz N, Castellsagué X, Berrington de González A, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24 (03, Suppl 3S): 1-10 https://www.ncbi.nlm.nih.gov/pubmed/16949995
- 9 Tsen HF, Morgenstern H, Mack T, Peters RK. Risk factors for penile cancer: results of a population-based case-control study in Los Angeles County (United States). Cancer Causes Control 2001; 12 (03) 267-277 https://www.ncbi.nlm.nih.gov/pubmed/11405332
- 10 Tang V, Clarke L, Gall Z. et al. Should centralized histopathological review in penile cancer be the global standard?. BJU Int 2014; 114 (03) 340-343 https://www.ncbi.nlm.nih.gov/pubmed/24053106
- 11 Afonso LA, Cordeiro TI, Carestiato FN, Ornellas AA, Alves G, Cavalcanti SM. High Risk Human Papillomavirus Infection of the Foreskin in Asymptomatic Men and Patients with Phimosis. J Urol 2016; 195 (06) 1784-1789 https://www.ncbi.nlm.nih.gov/pubmed/26796413
- 12 Kayes O, Minhas S, Allen C, Hare C, Freeman A, Ralph D. The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 2007; 51 (05) 1313-1318 , discussion 1318–1319 https://www.ncbi.nlm.nih.gov/pubmed/17113213
- 13 Petralia G, Villa G, Scardino E. et al. Local staging of penile cancer using magnetic resonance imaging with pharmacologically induced penile erection. Radiol Med (Torino) 2008; 113 (04) 517-528 https://www.ncbi.nlm.nih.gov/pubmed/18478188
- 14 Hanchanale V, Yeo L, Subedi N. et al. The accuracy of magnetic resonance imaging (MRI) in predicting the invasion of the tunica albuginea and the urethra during the primary staging of penile cancer. BJU Int 2016; 117 (03) 439-443 https://www.ncbi.nlm.nih.gov/pubmed/25600638
- 15 Bozzini G, Provenzano M, Romero Otero J. et al. Role of Penile Doppler US in the Preoperative Assessment of Penile Squamous Cell Carcinoma Patients: Results From a Large Prospective Multicenter European Study. Urology 2016; 90: 131-135 https://www.ncbi.nlm.nih.gov/pubmed/26776562
- 16 Mueller-Lisse UG, Scher B, Scherr MK, Seitz M. Functional imaging in penile cancer: PET/computed tomography, MRI, and sentinel lymph node biopsy. Curr Opin Urol 2008; 18 (01) 105-110 https://www.ncbi.nlm.nih.gov/pubmed/18090498
- 17 Leijte JA, Graafland NM, Valdés Olmos RA, van Boven HH, Hoefnagel CA, Horenblas S. Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int 2009; 104 (05) 640-644 https://www.ncbi.nlm.nih.gov/pubmed/19281465
- 18 Schlenker B, Scher B, Tiling R. et al. Detection of inguinal lymph node involvement in penile squamous cell carcinoma by 18F-fluorodeoxyglucose PET/CT: a prospective single-center study. Urol Oncol 2012; 30 (01) 55-59 https://www.ncbi.nlm.nih.gov/pubmed/20022269
- 19 Jakobsen JK, Nielsen TF, Ipsen P. et al. DaPeCa-7: Comparative Assessment of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (CT) and Conventional Diagnostic CT in Diagnosis of Lymph Node Metastases, Distant Metastases and Incidental Findings in Patients with Invasive Penile Cancer. BJU Int 2020;
- 20 Shabbir M, Muneer A, Kalsi J. et al. Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol 2011; 59 (01) 142-147 https://www.ncbi.nlm.nih.gov/pubmed/21050658
- 21 Manjunath A, Brenton T, Wylie S, Corbishley CM, Watkin NA. Topical Therapy for non-invasive penile cancer (Tis)-updated results and toxicity. Transl Androl Urol 2017; 6 (05) 803-808 https://www.ncbi.nlm.nih.gov/pubmed/29184776
- 22 Alnajjar HM, Lam W, Bolgeri M, Rees RW, Perry MJ, Watkin NA. Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 2012; 62 (05) 923-928 https://www.ncbi.nlm.nih.gov/pubmed/22421082
- 23 Bandieramonte G, Colecchia M, Mariani L. et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. Eur Urol 2008; 54 (04) 875-882 https://www.ncbi.nlm.nih.gov/pubmed/18243513
- 24 Colecchia M, Nicolai N, Secchi P. et al. pT1 penile squamous cell carcinoma: a clinicopathologic study of 56 cases treated by CO2 laser therapy. Anal Quant Cytol Histol 2009; 31 (03) 153-160 https://www.ncbi.nlm.nih.gov/pubmed/19639702
- 25 Piva L, Nicolai N, Di Palo A. et al. [Therapeutic alternatives in the treatment of class T1N0 squamous cell carcinoma of the penis: indications and limitations]. Arch Ital Urol Androl 1996; 68 (03) 157-161 https://www.ncbi.nlm.nih.gov/pubmed/8767503
- 26 Frimberger D, Hungerhuber E, Zaak D, Waidelich R, Hofstetter A, Schneede P. Penile carcinoma. Is Nd:YAG laser therapy radical enough?. J Urol 2002; 168 (06) 2418-2421 , discussion 2421 https://www.ncbi.nlm.nih.gov/pubmed/12441930
- 27 Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ. Long-term follow-up after laser therapy for penile carcinoma. Urology 2007; 69 (04) 759-762 https://www.ncbi.nlm.nih.gov/pubmed/17445665
- 28 Rothenberger KH, Hofstetter A. [Laser therapy of penile carcinoma]. Urologe A 1994; 33 (04) 291-294 https://www.ncbi.nlm.nih.gov/pubmed/7941174
- 29 Paoli J, Ternesten Bratel A, Löwhagen GB, Stenquist B, Forslund O, Wennberg AM. Penile intraepithelial neoplasia: results of photodynamic therapy. Acta Derm Venereol 2006; 86 (05) 418-421 https://www.ncbi.nlm.nih.gov/pubmed/16955186
- 30 Djajadiningrat RS, van Werkhoven E, Meinhardt W. et al. Penile sparing surgery for penile cancer-does it affect survival?. J Urol 2014; 192 (01) 120-125 https://www.ncbi.nlm.nih.gov/pubmed/24373799
- 31 Philippou P, Shabbir M, Malone P. et al. Conservative surgery for squamous cell carcinoma of the penis: resection margins and long-term oncological control. J Urol 2012; 188 (03) 803-808 https://www.ncbi.nlm.nih.gov/pubmed/22818137
- 32 Ornellas AA, Kinchin EW, Nóbrega BL, Wisnescky A, Koifman N, Quirino R. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 2008; 97 (06) 487-495 https://www.ncbi.nlm.nih.gov/pubmed/18425779
- 33 Smith Y, Hadway P, Biedrzycki O, Perry MJ, Corbishley C, Watkin NA. Reconstructive surgery for invasive squamous carcinoma of the glans penis. Eur Urol 2007; 52 (04) 1179-1185 https://www.ncbi.nlm.nih.gov/pubmed/17349734
- 34 Gotsadze D, Matveev B, Zak B, Mamaladze V. Is conservative organ-sparing treatment of penile carcinoma justified?. Eur Urol 2000; 38 (03) 306-312 https://www.ncbi.nlm.nih.gov/pubmed/10940705
- 35 Machan M, Brodland D, Zitelli J. Penile Squamous Cell Carcinoma: Penis-Preserving Treatment With Mohs Micrographic Surgery. Dermatol Surg 2016; 42 (08) 936-944 https://www.ncbi.nlm.nih.gov/pubmed/27467227
- 36 Leijte JA, Kirrander P, Antonini N, Windahl T, Horenblas S. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 2008; 54 (01) 161-168 https://www.ncbi.nlm.nih.gov/pubmed/18440124
- 37 van Bezooijen BP, Horenblas S, Meinhardt W, Newling DW. Laser therapy for carcinoma in situ of the penis. J Urol 2001; 166 (05) 1670-1671 https://www.ncbi.nlm.nih.gov/pubmed/11586199
- 38 Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumors. Urol Clin North Am 1992; 19 (02) 291-304 https://www.ncbi.nlm.nih.gov/pubmed/1574820
- 39 Shindel AW, Mann MW, Lev RY. et al. Mohs micrographic surgery for penile cancer: management and long-term followup. J Urol 2007; 178 (05) 1980-1985 https://www.ncbi.nlm.nih.gov/pubmed/17869306
- 40 Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology 1998; 52 (04) 559-565 https://www.ncbi.nlm.nih.gov/pubmed/9763071
- 41 Saisorn I, Lawrentschuk N, Leewansangtong S, Bolton DM. Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int 2006; 97 (06) 1225-1228 https://www.ncbi.nlm.nih.gov/pubmed/16686716
- 42 Stuiver MM, Djajadiningrat RS, Graafland NM, Vincent AD, Lucas C, Horenblas S. Early wound complications after inguinal lymphadenectomy in penile cancer: a historical cohort study and risk-factor analysis. Eur Urol 2013; 64 (03) 486-492 https://www.ncbi.nlm.nih.gov/pubmed/23490726
- 43 Koifman L, Hampl D, Koifman N, Vides AJ, Ornellas AA. Radical open inguinal lymphadenectomy for penile carcinoma: surgical technique, early complications and late outcomes. J Urol 2013; 190 (06) 2086-2092 https://www.ncbi.nlm.nih.gov/pubmed/23770135
- 44 Yao K, Tu H, Li YH. et al. Modified technique of radical inguinal lymphadenectomy for penile carcinoma: morbidity and outcome. J Urol 2010; 184 (02) 546-552 https://www.ncbi.nlm.nih.gov/pubmed/20620415
- 45 Hegarty PK, Dinney CP, Pettaway CA. Controversies in ilioinguinal lymphadenectomy. Urol Clin North Am 2010; 37 (03) 421-434 https://www.ncbi.nlm.nih.gov/pubmed/20674697
- 46 La-Touche S, Ayres B, Lam W, Alnajjar HM, Perry M, Watkin N. Trial of ligation versus coagulation of lymphatics in dynamic inguinal sentinel lymph node biopsy for staging of squamous cell carcinoma of the penis. Ann R Coll Surg Engl 2012; 94 (05) 344-346
- 47 Grabstald H. Controversies concerning lymph node dissection for cancer of the penis. Urol Clin North Am 1980; 7 (03) 793-799 http://www.ncbi.nlm.nih.gov/pubmed/7456188
- 48 Pizzocaro G, Piva L. Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 1988; 27 (6b): 823-824 https://www.ncbi.nlm.nih.gov/pubmed/2466471
- 49 Leijte JA, Kerst JM, Bais E, Antonini N, Horenblas S. Neoadjuvant chemotherapy in advanced penile carcinoma. Eur Urol 2007; 52 (02) 488-494 https://www.ncbi.nlm.nih.gov/pubmed/17316964
- 50 Bermejo C, Busby JE, Spiess PE, Heller L, Pagliaro LC, Pettaway CA. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. J Urol 2007; 177 (04) 1335-1338 https://www.ncbi.nlm.nih.gov/pubmed/17382727
- 51 Flaig T, Spiess P, Agarwal N, Rangs R, Boorjian S. et al. NCCN Clinical Practice Guidelines in Oncology Penile Cancer. Version 2. 2021
- 52 Pagliaro LC, Williams DL, Daliani D. et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 2010; 28 (24) 3851-3857 https://www.ncbi.nlm.nih.gov/pubmed/20625118
- 53 Dickstein RJ, Munsell MF, Pagliaro LC, Pettaway CA. Prognostic factors influencing survival from regionally advanced squamous cell carcinoma of the penis after preoperative chemotherapy. BJU Int 2016; 117 (01) 118-125 https://www.ncbi.nlm.nih.gov/pubmed/25294319
- 54 Lughezzani G, Catanzaro M, Torelli T. et al. The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience. J Urol 2014; 191 (04) 977-982 http://www.ncbi.nlm.nih.gov/pubmed/24262497
- 55 Tobias-Machado M, Tavares A, Ornellas AA, Molina Jr WR, Juliano RV, Wroclawski ER. Video endoscopic inguinal lymphadenectomy: a new minimally invasive procedure for radical management of inguinal nodes in patients with penile squamous cell carcinoma. J Urol 2007; 177 (03) 953-957 , discussion 958 https://www.ncbi.nlm.nih.gov/pubmed/17296386
- 56 Lont AP, Kroon BK, Gallee MP, van Tinteren H, Moonen LM, Horenblas S. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. J Urol 2007; 177 (03) 947-952 , discussion 952 http://www.ncbi.nlm.nih.gov/pubmed/17296384
- 57 Graafland NM, van Boven HH, van Werkhoven E, Moonen LM, Horenblas S. Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma. J Urol 2010; 184 (04) 1347-1353 https://www.ncbi.nlm.nih.gov/pubmed/20723934
- 58 Lucky MA, Rogers B, Parr NJ. Referrals into a dedicated British penile cancer centre and sources of possible delay. Sex Transm Infect 2009; 85 (07) 527-530 https://www.ncbi.nlm.nih.gov/pubmed/19584061
- 59 Giannatempo P.. et al. Survival analyses of adjuvant or neoadjuvant combination of a taxane plus cisplatin and 5-fluorouracil (T-PF) in patients with bulky nodal metastases from squamous cell carcinoma of the penis (PSCC): Results of a single high-volume center. Journal of Clinical Oncology 2014; 32 :4_suppl, 377-377 https://meetinglibrary.asco.org/record/90280/abstract
- 60 Nicolai N, Sangalli LM, Necchi A. et al. A combination of cisplatin and 5-fluorouracil with a taxane in patients who underwent lymph node dissection for nodal metastases from squamous cell carcinoma of the penis: treatment outcome and survival analyses in neoadjuvant and adjuvant settings. Clin Genitourin Cancer 2016; 14 (04) 323-330
- 61 Djajadiningrat RS, Bergman AM, van Werkhoven E, Vegt E, Horenblas S. Neoadjuvant taxane-based combination chemotherapy in patients with advanced penile cancer. Clin Genitourin Cancer 2015; 13 (01) 44-49
- 62 Bandini M, Pederzoli F, Necchi A. Neoadjuvant chemotherapy for lymph node-positive penile cancer: current evidence and knowledge. Curr Opin Urol 2020; 30 (02) 218-222
- 63 Pond GR, Di Lorenzo G, Necchi A. et al. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy. Urol Oncol 2014; 32 (04) 501-508 https://www.ncbi.nlm.nih.gov/pubmed/24332646
- 64 Eliason M, Bowen G, Bowen A, Hazard L, Samlowski W. Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy. Arch Dermatol 2009; 145 (08) 950-952 https://www.ncbi.nlm.nih.gov/pubmed/19687438
- 65 Noronha V, Patil V, Ostwal V, Tongaonkar H, Bakshi G, Prabhash K. Role of paclitaxel and platinum-based adjuvant chemotherapy in high-risk penile cancer. Urol Ann 2012; 4 (03) 150-153 https://www.ncbi.nlm.nih.gov/pubmed/23248520
- 66 Di Lorenzo G, Buonerba C, Federico P. et al. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU Int 2012; 110 (11 Pt B): E661-E666 https://www.ncbi.nlm.nih.gov/pubmed/22958571
- 67 Power DG, Galvin DJ, Cuffe S. et al. Cisplatin and gemcitabine in the management of metastatic penile cancer. Urol Oncol 2009; 27 (02) 187-190 https://www.ncbi.nlm.nih.gov/pubmed/18367122
- 68 Horenblas S, Newling DW. Local recurrent tumour after penis-conserving therapy. A plea for long-term follow-up. Br J Urol 1993; 72 (06) 976 https://www.ncbi.nlm.nih.gov/pubmed/8306171
- 69 Kroon BK, Horenblas S, Lont AP, Tanis PJ, Gallee MP, Nieweg OE. Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 2005; 173 (03) 816-819 https://www.ncbi.nlm.nih.gov/pubmed/15711276
- 70 Di Lorenzo G, Federico P, Buonerba C. et al. Paclitaxel in pretreated metastatic penile cancer: final results of a phase 2 study. Eur Urol 2011; 60 (06) 1280-1284
- 71 Tang DH, Djajadiningrat R, Diorio G. et al. Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study. Urol Oncol 2017; 35 (10) 605.e17-605.e23
- 72 Schover LR. Sexuality and fertility after cancer. Hematology (Am Soc Hematol Educ Program) 2005; 523: 523-527 https://www.ncbi.nlm.nih.gov/pubmed/16304430
- 73 Djajadiningrat RS, Teertstra HJ, van Werkhoven E, van Boven HH, Horenblas S. Ultrasound examination and fine needle aspiration cytology-useful for followup of the regional nodes in penile cancer?. J Urol 2014; 191 (03) 652-655 https://www.ncbi.nlm.nih.gov/pubmed/23994372
- 74 Li J, Zhu Y, Zhang SL. et al. Organ-sparing surgery for penile cancer: complications and outcomes. Urology 2011; 78 (05) 1121-1124 https://www.ncbi.nlm.nih.gov/pubmed/22054385
- 75 Romero FR, Romero KR, Mattos MA, Garcia CR, Fernandes RdeC, Perez MD. Sexual function after partial penectomy for penile cancer. Urology 2005; 66 (06) 1292-1295 https://www.ncbi.nlm.nih.gov/pubmed/16360459
- 76 Sosnowski R, Kulpa M, Kosowicz M. et al. Quality of life in penile carcinoma patients - post-total penectomy. Cent European J Urol 2016; 69 (02) 204-211 https://www.ncbi.nlm.nih.gov/pubmed/27551559
- 77 Hadway P. et al. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int 2006; 98 (03) 532-536
- 78 Austoni E.. et al. Reconstructive surgery for penile cancer with preservation of sexual function. Eur Urol Suppl, 2008. 7: 116 (Abstract #183). https://www.eusupplements.europeanurology.com/article/S1569-9056(08)60182-7/pdf